Medifast, Inc. (MED)

Medifast Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	99.42	143.57	164.03	102.86	77.92
Depreciation & Amortization	17.71	17.08	11.88	7.51	7.25
Share-Based Compensation	8.19	11.05	9.9	6.8	4.52
Other Operating Activities	22.34	22.87	-91.27	28.04	-5.42
Operating Cash Flow	147.66	194.57	94.55	145.2	84.26
Operating Cash Flow Growth	-24.11%	105.80%	-34.88%	72.32%	38.55%
Capital Expenditures	-6.48	-16.68	-34.21	-5.89	-10.06
Change in Investments	-54.56	5.27	5.15	4.61	3.73
Investing Cash Flow	-61.05	-11.41	-29.06	-1.28	-6.33
Dividends Paid	-73.02	-71.62	-63.86	-53.19	-35.4
Share Issuance / Repurchase	-6.96	-127.96	-62.09	-5.55	-47.21
Other Financing Activities	0.19	-	0.81	1.6	0.28
Financing Cash Flow	-79.79	-199.58	-125.13	-57.14	-82.32
Exchange Rate Effect	-0.07	-0.07	0.11	-0.02	0
Net Cash Flow	6.75	-16.49	-59.54	86.75	-4.39
Free Cash Flow	141.17	177.89	60.34	139.31	74.2
Free Cash Flow Growth	-20.64%	194.83%	-56.69%	87.74%	32.34%
Free Cash Flow Margin	13.17%	11.13%	3.95%	14.90%	10.40%
Free Cash Flow Per Share	12.97	15.89	5.16	11.84	6.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).